Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.

Viking Masek Packaging Technologies announced this week that two company leaders have transitioned into passive investors.

Wells Fargo raised the price target for the Viking Holdings Ltd. (NYSE:VIK) stock to “an Overweight”. The rating was released on May 28, 2024, according to finviz. The research report from Stifel has ...

Tyrell Hill signed a 4 yr 120M contract on March 23, 2022. In 2022, he played 800 snaps, caught 119 passes for 1,710 yards with 7 TDs. In 2023, he played 655 snaps, caught 119 passes for 1,799 yards ...

The company may look to license the experimental liver disease drug as it focuses on an obesity treatment that's shown early promise.

Viking Therapeutics is pulling up some extra long boats full of reasons the metabolic dysfunction associated steatohepatitis (MASH) drug VK2809 could be a winner, but executives were mum on exactly ...

Take a look →Mom and her child unearthed odd-shaped rock in garden. They found an ancient artifact →Farmer picks up 'trash' in field — then realizes he's holding rare Viking weapon The roughly ...

Joseph Pantginis has given his Buy rating due to a combination of factors surrounding Viking Therapeutics’ promising clinical trial results for its drug candidate VK2809. The drug demonstrated ...

Lee covers the Healthcare sector, focusing on stocks such as Viking Therapeutics, Corcept Therapeutics, and Wave Life Sciences. The word on The Street in general, suggests a Strong Buy analyst ...

Like the Big Three cruise companies, which have been bragging for months about their record booked position, Viking's bookings are through the roof.

It has only been modified to comply with this publication’s space and style. Viking Masek, a packaging equipment manufacturer, announces a significant transition as its ownership team, Robb Leonhard ...